Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
6%
ALSO IN XPH
XPH
54
HOLDINGS
14%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 3.7% | 2.4% | 2.4% |
|
JOHNSON & JOHNSON | 7.6% | 2.4% | 2.4% |
|
ELI LILLY & CO | 10.2% | 2.0% | 2.0% |
|
PFIZER INC | 2.0% | 2.1% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 2.3% | 1.6% |
IXJ Overweight Relative to XPH
|
ELI LILLY & CO | 8.2% |
|
JOHNSON & JOHNSON | 5.2% |
|
ABBVIE INC | 5.1% |
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.8% |
|
ROCHE HOLDING LTD | 3.7% |
|
UNITEDHEALTH GROUP INC | 3.3% |
|
AMGEN INC | 2.6% |
|
ABBOTT LABORATORIES | 2.4% |
|
GILEAD SCIENCES INC | 2.3% |
IXJ Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -3.0% |
|
EDGEWISE THERAPEUTICS, INC. | -2.5% |
|
ROYALTY PHARMA PLC CLASS A | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.3% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
 |
JAZZ PHARMACEUTICALS PLC | -2.2% |
|
SUPERNUS PHARMACEUTICALS INC | -2.2% |
|
ELANCO ANIMAL HEALTH, INC. | -2.2% |
|
INNOVIVA, INC. | -2.2% |